Moreover, the insulin receptor substrate 1 (IRS1) has been shown to be crucial for the generation of DTPs, and combinations of EGFR and IRS1 inhibitors were highly effective in models of EGFR-mutated lung cancer that were examined in animals [162]. Here, IRS1 is linked to lung carcinoma.